Reviewers: S Vasan (Henry M Jackson Foundation) | ๐๐๐๐๐ โข E Mills (McMaster University) | ๐๐๐๐๐
To read the original manuscript, click the link above.
Summary of Reviews: This preprint evaluated the effectiveness of ivermectin in shortening symptom duration or preventing hospitalization in people with mild-moderate COVID-19 symptoms. Both reviewers are in agreement that this study provides strong support for its claim that ivermectin does not seem to provide any clinically significant improvement in treatment outcomes.
Reviewer 1 (Sandhya V) | ๐๐๐๐๐
Reviewer 2 (Edward M) | ๐๐๐๐๐
To read the reviews, click the links below.ย